Previous models of TSS in HLA-DR1 mice required d-galactosamine pretreatment to elicit liver failure, an event that is entirely related to tumor necrosis factor (TNF)-induced hepatocyte apoptosis in the d-galactosamine setting, while SEB alone results in cytokine release only (16). The gene discussed is SETBP1; the disease is liver failure.